Cargando…
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
Residents of long-term care facilities (LTCFs) have been dramatically hit by the COVID-19 pandemic on a global scale as older age and comorbidities pose an increased risk of severe disease and death. The aim of the study was to assess the quantity and durability of specific antibody responses to SAR...
Autores principales: | Lai, Alessia, Caimi, Barbara, Franzetti, Marco, Bergna, Annalisa, Velleca, Rossella, Gatti, Antonella, Rossi, Pier Luigi, D’Orso, Marco, Pregliasco, Fabrizio, Balotta, Claudia, Calicchio, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954729/ https://www.ncbi.nlm.nih.gov/pubmed/35335078 http://dx.doi.org/10.3390/vaccines10030446 |
Ejemplares similares
-
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention
por: Caimi, Barbara, et al.
Publicado: (2022) -
Decline of immune humoral response after BNT162b2 vaccine
por: Ferri, Sonia, et al.
Publicado: (2022) -
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History
por: Tarkowski, Maciej, et al.
Publicado: (2021) -
Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
por: Anastasi, Emanuela, et al.
Publicado: (2022) -
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
por: Miyazaki, Ryoichi, et al.
Publicado: (2023)